Trademark Attorney / Law Firm

John Paul J. Oleksiuk – Trademark Portfolio

John Paul J. Oleksiuk specializes in Class 42 (Computer & Scientific) trademark filings before the United States Patent and Trademark Office (USPTO), with 1 of 2 total filings concentrated in this category. The practice also covers Class 36 (Insurance & Financial) along with 2 other Nice Classification classes. Filing activity spans from 2018 to 2025. Currently, 2 trademarks are registered.

2 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

John Paul J. Oleksiuk's trademark practice covers 2 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

36
Insurance & Financial (1 filing)

Insurance; financial affairs; monetary affairs; real estate affairs

Frequently Asked Questions

How many trademark applications has John Paul J. Oleksiuk filed?

John Paul J. Oleksiuk has filed 2 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 2 registered.

What trademark classes does John Paul J. Oleksiuk specialize in?

John Paul J. Oleksiuk has filed trademarks across 2 Nice Classification classes. The most common practice areas include Class 42 (Computer & Scientific), Class 36 (Insurance & Financial). Class 42 covers scientific and technological services; industrial analysis and research services.

How long has John Paul J. Oleksiuk been filing trademarks?

John Paul J. Oleksiuk's trademark filing history with the USPTO spans from 2018 to 2025, covering 7 years of trademark practice. During this period, John Paul J. Oleksiuk has handled 2 trademark applications.

What is John Paul J. Oleksiuk's trademark registration success rate?

John Paul J. Oleksiuk has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.